echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Right Meshafin/Quinitin relieves diabetic neuropathy pain

    Right Meshafin/Quinitin relieves diabetic neuropathy pain

    • Last Update: 2020-07-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    a phase III study conducted in the United States and Israel recently found that the right mesafen/quinydine had a significant pain-relieving effect on diabetic nerve painIn the trial, 379 patients with diabetic nerve pain were randomly treated with a right mesafen/quininin ratio of 45 mg/30 mg, 30 mg/30 mg or placebo, twice a dayThe primary endpoint is based on the pain level scale recorded on a daily basisAt 30 days, 60 days and 90 days of administration, the average decrease in 45 mg/30 mg right mesafen/quinydine group was significantly higher than in the placebo group; Active therapy is also associated with significant improvements in the pain relief scale and the pain intensity scaleThe most commonadverse reactions are dizziness, nausea, diarrhea, tiredness and drowsinessAlthough there was no significant difference in the incidence of severeadverse reactions between 45 mg/30 mg, right mesafen/quininidine and the incidence of severeadverse reactions between the right mesafen/quinnitin and theincidence of the placebo group (7.6%, 4.8% and 4.1%, respectively), the proportion of patients in the two treatment groups who were interrupted byadverse reactionswas significantly higher than in the placebo group (25.2% and 21% vs11.4%, respectively)(Golden)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.